Paragon Bioservices (now Catalent)
Baltimore, MD, USA CDMO Founded 1999 501-1000 employees
Gene therapy-focused CDMO providing viral vector manufacturing for adeno-associated virus (AAV) gene therapies, acquired by Catalent to expand biologics capabilities.
Services
Therapeutic Areas
Certifications
Regulatory Experience
FDAEMA